IMCR
Price
$30.98
Change
-$1.14 (-3.55%)
Updated
Oct 23 closing price
Capitalization
1.6B
11 days until earnings call
Intraday BUY SELL Signals
SPRB
Price
$45.15
Change
-$0.85 (-1.85%)
Updated
Oct 23 closing price
Capitalization
129.76M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMCR vs SPRB

IMCR vs SPRB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMCR vs. SPRB commentary
Oct 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCR is a Hold and SPRB is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMCR with price predictions
Oct 23, 2026

IMCR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IMCR turned positive on October 15, 2026. Looking at past instances where IMCR's MACD turned positive, the stock continued to rise in 41 of 47 cases over the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMCR's RSI Indicator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on IMCR as a result. In 56 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

Following a +10.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMCR advanced for three days, in 219 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 52 cases where IMCR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

IMCR broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IMCR entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.800) is normal, around the industry mean (3.035). IMCR has a moderately low P/E Ratio (-86.056) as compared to the industry average of (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (3.791) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. IMCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SPRB with price predictions
Oct 23, 2026

SPRB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 13, 2026

SPRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 32 cases where SPRB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SPRB's RSI Oscillator exited the oversold zone, 22 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on SPRB as a result. In 77 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for SPRB just turned positive on October 21, 2026. Looking at past instances where SPRB's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.

Following a +11.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRB advanced for three days, in 202 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

SPRB moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPRB crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for SPRB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.550) is normal, around the industry mean (3.035). P/E Ratio (-1.175) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (53.476) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. SPRB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
SPRB: Fundamental Ratings
SPRB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
41
SEASONALITY SCORE
1..100
28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCRSPRB
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
82%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
83%
COMPARISON
Comparison
Oct 25, 2026
Stock price -- (IMCR: $30.98 vs. SPRB: $45.15)
Brand notoriety: IMCR and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMCR: 39% vs. SPRB: 89%
Market capitalization -- IMCR: $1.6B vs. SPRB: $129.76M
IMCR [@Biotechnology] is valued at $1.6B. SPRB’s [@Biotechnology] market capitalization is $129.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCR’s FA Score shows that 2 FA rating(s) are green while SPRB’s FA Score has 0 green FA rating(s).

  • IMCR’s FA Score: 2 green, 3 red.
  • SPRB’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCR is a better buy in the long-term than SPRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCR’s TA Score shows that 4 TA indicator(s) are bullish while SPRB’s TA Score has 5 bullish TA indicator(s).

  • IMCR’s TA Score: 4 bullish, 4 bearish.
  • SPRB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IMCR and SPRB are a good buy in the short-term.

Price Growth

IMCR (@Biotechnology) experienced а +5.37% price change this week, while SPRB (@Biotechnology) price change was +13.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

IMCR is expected to report earnings on Nov 05, 2026.

SPRB is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMCR
Daily Signal:
Gain/Loss:
SPRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LIAM216.36N/A
N/A
LifeX 2055 Inflation-Protected Longevity Income ETF (LIAM)
HFXI36.07-0.04
-0.11%
NYLIM FTSE International Equity Currency Neutral ETF (HFXI)
WEA9.62-0.06
-0.62%
Western Asset Premier
DFJ112.11-0.98
-0.87%
WisdomTree Japan SmallCap Dividend Fund (DFJ)
FLGR31.90-0.28
-0.87%
Franklin FTSE Germany ETF (FLGR)

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with SLDB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-3.55%
SLDB - IMCR
45%
Loosely correlated
-4.36%
SANA - IMCR
44%
Loosely correlated
-1.69%
ARVN - IMCR
42%
Loosely correlated
-5.44%
XNCR - IMCR
42%
Loosely correlated
-2.55%
IMTX - IMCR
42%
Loosely correlated
-3.05%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with IMRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then IMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-1.85%
IMRX - SPRB
52%
Loosely correlated
-2.10%
MLEC - SPRB
51%
Loosely correlated
+2.08%
ANRO - SPRB
37%
Loosely correlated
-1.04%
FLNA - SPRB
36%
Loosely correlated
-2.84%
COYA - SPRB
35%
Loosely correlated
-4.83%
More